These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 9461198)

  • 21. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
    Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC
    Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke.
    García-Culebras A; Palma-Tortosa S; Moraga A; García-Yébenes I; Durán-Laforet V; Cuartero MI; de la Parra J; Barrios-Muñoz AL; Díaz-Guzmán J; Pradillo JM; Moro MA; Lizasoain I
    Stroke; 2017 Jun; 48(6):1695-1699. PubMed ID: 28428349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
    Zhang C; An J; Haile WB; Echeverry R; Strickland DK; Yepes M
    J Cereb Blood Flow Metab; 2009 Dec; 29(12):1946-54. PubMed ID: 19672275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroserpin protects neurons from ischemia-induced plasmin-mediated cell death independently of tissue-type plasminogen activator inhibition.
    Wu J; Echeverry R; Guzman J; Yepes M
    Am J Pathol; 2010 Nov; 177(5):2576-84. PubMed ID: 20864675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact.
    Roussel BD; Macrez R; Jullienne A; Agin V; Maubert E; Dauphinot L; Potier MC; Plawinski L; Castel H; Hommet Y; Munuera J; Montaner J; Yepes M; Ali C; Vivien D
    Brain; 2009 Aug; 132(Pt 8):2219-30. PubMed ID: 19574439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue-type plasminogen activator mediates neuronal detection and adaptation to metabolic stress.
    Wu F; Nicholson AD; Haile WB; Torre E; An J; Chen C; Lee AK; Duong DM; Dammer EB; Seyfried NT; Tong FC; Votaw JR; Yepes M
    J Cereb Blood Flow Metab; 2013 Nov; 33(11):1761-9. PubMed ID: 23881246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator.
    Tsirka SE; Gualandris A; Amaral DG; Strickland S
    Nature; 1995 Sep; 377(6547):340-4. PubMed ID: 7566088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication.
    Nakano T; Irie K; Hayakawa K; Sano K; Nakamura Y; Tanaka M; Yamashita Y; Satho T; Fujioka M; Muroi C; Matsuo K; Ishikura H; Futagami K; Mishima K
    Brain Res; 2015 Oct; 1624():330-335. PubMed ID: 26254727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus.
    Tsirka SE; Rogove AD; Bugge TH; Degen JL; Strickland S
    J Neurosci; 1997 Jan; 17(2):543-52. PubMed ID: 8987777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotection by urokinase plasminogen activator in the hippocampus.
    Cho E; Lee KJ; Seo JW; Byun CJ; Chung SJ; Suh DC; Carmeliet P; Koh JY; Kim JS; Lee JY
    Neurobiol Dis; 2012 Apr; 46(1):215-24. PubMed ID: 22293605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prothymosin alpha and its mimetic hexapeptide improve delayed tissue plasminogen activator-induced brain damage following cerebral ischemia.
    Halder SK; Matsunaga H; Ueda H
    J Neurochem; 2020 Jun; 153(6):772-789. PubMed ID: 31454420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective role of tuftsin fragment 1-3 in an animal model of intracerebral hemorrhage.
    Wang J; Rogove AD; Tsirka AE; Tsirka SE
    Ann Neurol; 2003 Nov; 54(5):655-64. PubMed ID: 14595655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
    Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
    Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibiting 12/15-lipoxygenase to treat acute stroke in permanent and tPA induced thrombolysis models.
    Karatas H; Eun Jung J; Lo EH; van Leyen K
    Brain Res; 2018 Jan; 1678():123-128. PubMed ID: 29079502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
    Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
    Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M; Asahi K; Wang X; Lo EH
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia.
    Asahi M; Huang Z; Thomas S; Yoshimura S; Sumii T; Mori T; Qiu J; Amin-Hanjani S; Huang PL; Liao JK; Lo EH; Moskowitz MA
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):722-9. PubMed ID: 15716855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an
    Cheon SY; Kim SY; Kam EH; Lee JH; Kim JM; Kim EJ; Kim TW; Koo BN
    Int J Med Sci; 2017; 14(5):425-433. PubMed ID: 28539818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased neural damage after spinal cord injury in tPA-deficient mice.
    Abe Y; Nakamura H; Yoshino O; Oya T; Kimura T
    J Neurotrauma; 2003 Jan; 20(1):43-57. PubMed ID: 12614587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.